Get started

Bullish Divergence

PYPL | Perfect Entry Point | BouncePayPal Holdings, Inc. operates a technology platform that enables digital payments on behalf of merchants and consumers worldwide. It provides payment solutions under the PayPal, PayPal Credit, Braintree, Venmo, Xoom, Zettle, Hyperwallet, Honey, and Paidy names. The company's payments platform allows consumers to send and receive payments in approximately 200 markets and in approximately 100 currencies, withdraw funds to their bank accounts in 56 currencies, and hold balances in their PayPal accounts in 25 currencies. PayPal Holdings, Inc. was founded in 1998 and is headquartered in San Jose, California.
NASDAQ:PYPLLong
by DivergenceSeeker
1
SHFS | Another Money Maker | LONGSHF Holdings, Inc., through its subsidiaries, provides access to banking, lending, and other financial services to financial institutions serving the cannabis industry. The company, through its proprietary platform, offers access to business checking and savings accounts, cash management accounts, savings and investment options, commercial lending, courier services, remote deposit services, automated clearing house payments and origination, and wire payments. Its services allow cannabis related businesses to obtain services from financial institutions that allow them to run their business with enhanced financial insight into their business and access to resources. The company was founded in 2015 and is based in Arvada, Colorado.
NASDAQ:SHFSLong
by DivergenceSeeker
1
FINALLY Bitcoin 36K test soon??June of last year I published a post about bitcoin and the possibility of a coming bear market rally to 36k once the 18k support level finally broke down (approximate). Well the first week of November this occurred and although we did not get the deep capitulation we would have liked to see, we find ourselves in an interesting situation with the new data we have now to go off of. The primary piece of information being that of getting back above 18k after a failed attempt a week or so before Christmas. I did not post anything at the time of that occurring because I was not sold on the idea that it was legitimate. But fast forward to the middle of January and on the weekly chart of Bitcoin we now have not only the break back above 18k, but also classic bullish divergence showing on the weekly RSI indicator. And if we look at the weekly RSI we can also see that there is A LOT of room to run to the upside after consolidating for SEVEN MONTHS after first going oversold in June. And we are now getting confirmation of this bullish divergence that we were patiently waiting on by taking out the 18k resistance level and now attempting to close back above it. Keep an eye on the Sunday close of this weekly candle on Bitcoin. As well as the coming US CPI data that is going to be released tomorrow. If BTC can hold above this 18k level, there could be a major move to the upside that could take us well past the main target of $36000 on Bitcoin. Meanwhile, the short term first target for this asset (if 18k holds) would be $21500.
INDEX:BTCUSDLong
by TradeVibez
1
SQZ | SQueeZe This One | LONGSQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with other immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. SQZ Biotechnologies Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.
SLong
by DivergenceSeeker
2
EBON | Oversold Crypto Play | BounceEbang International Holdings Inc., through its subsidiaries, engages in the research, design, and development of application-specific integrated circuit chips and manufacture of Bitcoin mining machines under the Ebit brand in China, the United States, Hong Kong, and internationally. It also provides mining machine hosting services that enable customers to operate mining machines remotely; and routine maintenance services, as well as engages in the development of proprietary cryptocurrency exchange platform. In addition, the company offers fiber-optic communication access devices, including multiprotocol label switching fiber-optic access network devices, multi-service access platform integrated business access devices, and wavelength-division multiplexing fiber-optic devices; and enterprise convergent terminal products, which consists gigabit passive optical network, enterprise cloud gateway devices, industrial Internet of Things access devices, and business enterprise smart wireless access devices. It serves the blockchain and telecommunications industries. The company also provides foreign exchange trading and digital currency transfer services, as well as deals in virtual currencies. It sells its blockchain products directly, as well as through its website; and telecommunication products under the EBANG brand name primarily through supplier contracts. The company was incorporated in 2018 and is headquartered in Hangzhou, China.
NASDAQ:EBONLong
by DivergenceSeeker
3
USDCAD Bullish Setup - Trade SignalUSDCAD has been sliding within a Complex Corrective Pattern. This is telling me that an Elliott Wave Impulse could be around the corner. DXY can bounce for a come-back due to its pending Bullish Divergence. All other FX-Majors (EURUSD, GBPUSD, USDCHF, USDJPY, AUDUSD, NZDUSD) are onto Reversals. “Difficult to see; always in motion is the future.” — Yoda My Loonie Technicals: * Elliott Wave Complex Correction: Triple Three * Harmonic Pattern: AB=CD * 78.6-88.6% Fibonacci Retracement * 127.2-161.8% Fibonacci Extension * Demand Zone * Bullish Divergence USDCAD LONG Signal: * Aggressive Entry @ 1.3380 with SL @ 1.3150 * Moderate Entry @ with SL @ 1.3050 * TP1 @ 1.3685 * TP2 @ 1.380 * TP3 @ 1.390 * Safety Measure: when in the green, moving SL to BE. * BUY Stops on the way up, after pull-backs. Many pips ahead! Richard, the Wave Jedi.
Long
by Lionheart-EWA
2
SOPA | Good Time to Enter | LONGSociety Pass Incorporated engages in the acquisition and operation of e-commerce platforms for consumers and merchants in Southeast Asia. It operates in two segments, E-Commerce and Merchant POS. The company's e-commerce interfaces include lifestyle platforms, such as Leflair App and Leflair.com website; food and beverage (F&B) delivery platforms comprising Pushkart App, Pushkart.ph website, Handycart App, and Handycart.vn website; merchant software segment that consists of #HOTTAB Biz App, #HOTTAB POS App, and Hottab.net website; and loyalty platforms, such as Society Pass App and SoPa.asia website. Its loyalty-focused and data-driven e-commerce marketing platform interfaces connect consumers with merchants in the F&B and lifestyle sectors. The company was formerly known as Food Society, Inc. and changed its name to Society Pass Incorporated in October 2018. Society Pass Incorporated was incorporated in 2018 and is headquartered in Singapore.
NASDAQ:SOPALong
by DivergenceSeeker
2
MNK | Lets Get It | BounceMallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, pulmonology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes; and gastrointestinal products. It offers Acthar Gel, a repository corticotropin injection for rheumatoid arthritis, infantile spasms, systemic lupus erythematosus, multiple sclerosis, systemic dermatomyositis, symptomatic sarcoidosis, severe acute and chronic allergic, and inflammatory diseases; INOmax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Therakos photopheresis, an immunotherapy treatment platform; Amitiza for constipation; and StrataGraft for the treatment of adults with deep partial-thickness burns. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; and SLN 501 is a ribonucleic acid silencing therap. In addition, it provides specialty generic drugs and active pharmaceutical ingredients. The company markets its branded products to physicians, respiratory therapists, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with Silence Therapeutics plc to develop and commercialize ribonucleic acid interference drug targets. The company was founded in 1867 and is based in Dublin, Ireland.
MLong
by DivergenceSeeker
USDJPY LONG: Bullish RetracementUSDJPY is finally ready to bounce to the up-side. The Elliott Wave Diagonal (Wedge) is certainly saying that. XAUUSD is diverging, EURUSD found a top and the DXY looks ready to bounce. My Technicals on USDJPY: * Elliott Wave Reversal * Leading Diagonal in Primary A (red) * Bullish Divergence * Harmonic Pattern: Bullish Shark * Demand Zone * Fibonacci Extension Confluence * Golden Ratio Fibonacci Retracement USDJPY LONG Signal: * Entry @ 132.00 * SL @ 122.00 * TP1 @ 137.90 * TP2 @ 143.30 * TP3 @ 149.30 * Safety Measure: when in the green, moving SL to BE. * BUY Stops on the way up, after pull-backs. Many pips ahead! Richard, the Wave Jedi.
Long
by Lionheart-EWA
4
USDJPY - Bullish Impulse - Minor CUSDJPY is preparing to shoot on the up-side, with a Bullish Impulse, ahead of the FOMC (FED). Expected swing: Minor C (white), of Intermediate (B) (red) completion. A spike in the Dollar would be expected on the FOMC Press Conference. USDJPY Tech. Analysis: * Elliott Wave: Intermediate (A) (red) complete * Fibonacci Extension Confluence (Minors A-B-C (red)) * Minor B (white) Double Bottom * Harmonic Pattern: Bullish Cypher * Bullish Divergence * 88.6% Fibonacci Retracement USDJPY Trading Signal: * Entry @ 134.150 * SL @ 131.00 & 126.000 * TP1 @ 145.00 * TP2 @ 149.855 * Buy Stop Level @ 138.00 * Aggressive Entry @ Market Price * Conservative Entry @ 133.10 *Safety Measure: when in the green, moving SL to BE. Many pips ahead! Richard, the Wave Jedi.
Long
by Lionheart-EWA
12
HYFM | Oversold Agriculture Play | LongHydrofarm Holdings Group, Inc., together with its subsidiaries, engages in the manufacture and distribution of controlled environment agriculture (CEA) equipment and supplies in the United States and Canada. The company offers agricultural lighting devices, indoor climate control equipment, hydroponics and nutrients, and plant additives used to grow, farm, and cultivate cannabis, flowers, fruits, plants, vegetables, grains, and herbs in controlled environment; and distributes CEA equipment and supplies, which include grow light systems; heating, ventilation, and air conditioning systems; humidity and carbon dioxide monitors and controllers; water pumps, heaters, chillers, and filters; nutrient and fertilizer delivery systems; and various growing media made from soil, rock wool or coconut fiber. It also provides hydroponics systems, such as hydro systems, hydro trays and components, meters and solutions, pumps and irrigation systems, water filtration systems, pots and containers, and tents and tarps; atmospheric control equipment comprising controllers, monitors and timers, ventilation/air conditioning equipment, air purification equipment, and CO2 equipment; and nutrients and additives. The company offers its products under the Phantom, PhotoBio, Active Aqua, Active Air, HEAVY 16, House & Garden, Mad Farmer, Roots Organics, Soul, Procision, Grotek, Gaia Green, Innovative Growers Equipment, Quantum, Xtrasun, Digilux, Agrobrite, SunBlaster, Jump Start, Active Eye, Autopilot, Phat, oxyClone, and GROW!T brands. Hydrofarm Holdings Group, Inc. was founded in 1977 and is based in Shoemakersville, Pennsylvania.
NASDAQ:HYFMLong
by DivergenceSeeker
5
WKSP | Great Entry Point | LONGWorksport Ltd., through its subsidiary, designs, manufactures, and distributes truck tonneau covers in Canada and the United States. The company offers soft cover (SC) and tough cover (TC) tonneau covers, including SC3, a tri-fold cover that seals around the truck bed with a rubber gasket designed to protect cargo from moisture and debris; SC3pro that allows the operator to open the cover by pulling a release cable; and TC3, a thick aluminum tri-cover panel with a honey-comb core coated in a durable black scratch-resistant powder coating. It is also developing TerraVis, a solar cover tonneau cover that gives rechargeable portable power to pickup truck owners. The company distributes its products through wholesalers and online retail channels. It serves private labels and original equipment manufacturers. Worksport Ltd. has a collaboration agreement with Greatcell Energy Pty Ltd. The company was formerly known as Franchise Holdings International, Inc. and changed its name to Worksport Ltd. in May 2020. Worksport Ltd. is based in Vaughan, Canada.
NASDAQ:WKSPLong
by DivergenceSeeker
3
TOTAL2: ALTS RELIEF BOUNCE INCOMING!!Hello everyone, if you like the idea, do not forget to support it with a like and follow. Welcome to this TOTAL2 aka ALT MARKET CAP update. As 2022 is ending and this year might be not good for us but hope 2023 will be the best year for everyone and you guys make a lot of money this year. According to the chart, Total2 is an important support level and currently holds this support very well. We can expect a bounce from here. It means we see some relief rally in Alts in the first two weeks of 2023. Rsis also shows bullish divergence. Invalidation level:- Daily close below $430B If you like this idea then do support it with like and follow. Also, share your views in the comment section. Wish you a very happy new year everyone. Hope this year brings lots of joy and happiness in your life. Thank You!
CRYPTOCAP:TOTAL2Long
by CoreCrypto1
5
FATE | Incoming Rally - Oversold | LONGFate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
NASDAQ:FATELong
by DivergenceSeeker
1
PRSO | The Perfect Bullish Setup | LONGPeraso Inc. operates as a fabless semiconductor company, develops, markets, and sells semiconductor devices and modules. It focuses on development of millimeter wavelength (mmWave) for the 60 gigahertz, spectrum, and for 5G cellular networks. The company's products include mmWave ICs, including baseband IC, various mmWave radio frequency, integrated circuits, as well as associated antenna technology; and mmWave modules. It also provides accelerator engine products, comprising bandwidth engine for high-performance applications where throughput is critical; and programmable hyperspeed engine to allow user-defined functions or algorithms. In addition, the company offers quad partition rate which allows for parallel accesses to multiple partitions of the memory simultaneously. Its mmWave products enable various applications, such as 5G with low latency and high reliability, multi-gigabit, mmWave links over 25 kilometers, as well as consumer applications, such as wireless video streaming, and untethered augmented reality and virtual reality. The company also licenses intellectual property, as well as offers non-recurring engineering services. It markets its products through direct sales personnel, as well as sells representatives and distributors. The company was formerly knowns as MoSys, Inc. and changed its name to Peraso Inc. in December 2021. Peraso Inc. was incorporated in 1991 and is based in San Jose, California.
NASDAQ:PRSOLong
by DivergenceSeeker
2
DERM | Good Entry Point | OversoldJourney Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
NASDAQ:DERMLong
by DivergenceSeeker
4
INM | This is a Runner | LONGInMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. The company operates through two segments, the InMed and the BayMedica. The InMed segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. The company's prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with high unmet medical needs. Its lead product is INM-755, a cannabinol topical skin cream, which is in Phase 2 clinical trial for the treatment of epidermolysis bullosa. The company is also developing INM-088, which is in preclinical studies for the treatment of glaucoma; INM-405 for the treatment of pain; and cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. In addition, it offers IntegraSyn, an integrated biosynthesis-based manufacturing approach, for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
NASDAQ:INMLong
by DivergenceSeeker
VIRX | I Like These Setups | OversoldViracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket trial for the treatment of various relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as well as an open-label Phase 1b/2 trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. The company's development pipeline includes vecabrutinib, a clinical-stage non-covalent ITK/BTK inhibitor and VRx-510 (formerly SNS-510), a preclinical-stage PDK-1 inhibitor. It is evaluating development and collaboration opportunities for vecabrutinib in combination with chimeric antigen receptor T-cell therapies and VRx-510 in various oncology indications. The company was formerly known as Sunesis Pharmaceuticals, Inc. to Viracta Therapeutics, Inc. in February 25, 2021. Viracta Therapeutics, Inc. was incorporated in 1998 and is headquartered in Cardiff-by-the-Sea, California.
NASDAQ:VIRXLong
by DivergenceSeeker
1
BKYI | Nice Oversold Condition | LONGBIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
NASDAQ:BKYILong
by DivergenceSeeker
4
CF | Good Entry Point | LONGCF Industries Holdings, Inc. manufactures and sells hydrogen and nitrogen products for energy, fertilizer, emissions abatement, and other industrial activities worldwide. Its principal products include anhydrous ammonia, granular urea, urea ammonium nitrate, and ammonium nitrate products. The company also offers diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia products; and compound fertilizer products with nitrogen, phosphorus, and potassium. It primarily serves cooperatives, independent fertilizer distributors, traders, wholesalers, and industrial users. The company was founded in 1946 and is headquartered in Deerfield, Illinois.
NYSE:CFLong
by DivergenceSeeker
1